Skip to search formSkip to main contentSkip to account menu

0.8 ML FILGRASTIM-SNDZ 0.6 MG/ML Prefilled Syringe

Known as: filgrastim-SNDZ 480 MCG per 0.8 ML Prefilled Syringe, filgrastim-sndz 480 MCG in 0.8 ML Prefilled Syringe, FILGRASTIM-SNDZ 600MCG/ML (PF) INJ,SYRINGE,0.8ML 
National Institutes of Health

Related topics

Related topics

7 relations
Drug AllergyFilgrastimGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating Factor

Broader (1)

Hematinics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Efficacy and Cost Savings Associated with a Conversion from Filgrastim to Filgrastim-Sndz in Stem Cell Transplant Patients Undergoing Mobilization
2019
2019
Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectiveness
To describe utilization of filgrastim and infliximab, the first two products with biosimilars approved in the United States. 
2019
2019
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact…
BACKGROUND Granulocyte colony-stimulating factors (G-CSFs) are often administered to reduce the incidence, severity, and duration… 
2017
2017
Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States
Abstract Introduction: Granulocyte colony-stimulating factors (G-CSFs), when used to reduce the incidence, severity, and duration… 
2017
2017
Expanded Access to Obinutuzumab from Cost-Savings Generated By Biosimilar Filgrastim-Sndz in the Prophylaxis of Chemotherapy-Induced (Febrile) Neutropenia: US Simulation Study
BACKGROUND: Prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim-sndz (EP2006) may generate cost… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)